Liverpool success at global Bio event
Liverpool's life science community returns home from the world’s largest global biotech event today [Friday June 22], delighted with reaction to the city’s growing reputation.
Dr Geoff Wainwright of 2Bio Ltd and Dr Neil Murray of Redx Pharma represented Liverpool at the BIO International Convention in Boston, USA to explain the extent of Liverpool’s ambition and excellence.
Some 25,000 delegates from more than 65 countries attended the convention, which highlighted the latest trends and opportunities for executives, investors, scientists and policy leaders.
Geoff Wainwright said: “Under our Liverpool Life Sciences brand, we have highlighted the excellent work going on in Liverpool's Universities and Hospitals, and in our Life Sciences industry. Many of the people we have met have been interested in Liverpool and what it offers. We will continue to speak with them about the potential our City offers for their businesses to establish new projects or to locate their businesses in to. An unexpected and pleasant outcome has been the number of Liverpool-born executives we have met and have been able to tell them of the great changes the City has undergone since they left."
Dr Neil Murray of Redx Pharma added: “Bio does attract a large number of deal makers and we’ve been able to make new contacts as well as affirm our relationships with existing partners.”
George Freeman MP, the Life Sciences Advisor to Rt Hon David Willets MP, also attended Bio, commented: “Liverpool illustrates the strengths of the UK as a global translational medicine hub. It’s combination of long recognised clinical research excellence, top-rated University and patient catchment comprising one of England’s largest conurbations, with a regrettably high-incidence of key target diseases, means that it is an attractive place for inward investment.”
Life sciences are a critical part of the Liverpool City Region’s Knowledge Economy plan and the city’s presence at the Boston event is supported and part-financed through LCR Local Enterprise Partnership’s European funding.
The Convention also featured the BIO Business Forum, a unique platform for biotechnology and pharmaceutical companies, academic research institutions and investors from around the world to gather and discuss strategic opportunities.
Dr Wainwright and Dr Murray worked closely with Kristen Hirst, Liverpool Vision’s director for It’s Liverpool in the USA who will build the city’s US bio strategy and follow up on leads from the conference.
Max Steinberg, chief executive of Liverpool Vision, added: “Science and innovation lie at the heart of Liverpool’s strategy for growth.
“Liverpool already has an important Knowledge Quarter which boasts a breath-taking and unrivalled combination of knowledge assets which reach out to every corner of the world and every aspect of modern life.
“Our ambition is huge and we are actively looking to secure a 2m sq ft Biocampus, encompassing one of Europe’s biggest clusters of bio-businesses, research facilities and a state of the art new teaching hospital.”
“There is a real affinity between our ambition and our approach because Liverpool is a location where entrepreneurial businesses like Redx Pharma can find the right support and conditions to reach their own aspirations.”
[Image: Left to right Dr Geoff Wainwright Dr Neil Murray]